
The authors summarize the results of the September 2000 PhRMA workshop discussions about conducting out-of-specification investigations.
Richard J. Davis most recently was the senior vice- president for quality assurance and regulatory compliance for DuPont Pharmaceuticals Company, Wilmington, DE.

The authors summarize the results of the September 2000 PhRMA workshop discussions about conducting out-of-specification investigations.

Published: January 1st 2002 | Updated: